Short Communication: High Rates of Thymidine Analogue Mutations and Dual-Class Resistance Among HIV-Infected Ugandan Children Failing First-Line Antiretroviral Therapy
-
- Kim C.E. Sigaloff
- PharmAccess Foundation Amsterdam, The Netherlands.
-
- Joshua Kayiwa
- Joint Clinical Research Centre, Kampala, Uganda.
-
- Victor Musiime
- Joint Clinical Research Centre, Kampala, Uganda.
-
- Job C.J. Calis
- Global Child Health Group, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
-
- Elizabeth Kaudha
- Joint Clinical Research Centre, Kampala, Uganda.
-
- Andrew Mukuye
- Joint Clinical Research Centre, Mbale, Uganda.
-
- Christine Matama
- Joint Clinical Research Centre, Fort Portal, Uganda.
-
- Immaculate Nankya
- Joint Clinical Research Centre, Kampala, Uganda.
-
- Lillian Nakatudde
- Joint Clinical Research Centre, Kampala, Uganda.
-
- John T. Dekker
- PharmAccess Foundation Amsterdam, The Netherlands.
-
- Raph L. Hamers
- PharmAccess Foundation Amsterdam, The Netherlands.
-
- Peter Mugyenyi
- Joint Clinical Research Centre, Kampala, Uganda.
-
- Tobias F. Rinke De Wit
- PharmAccess Foundation Amsterdam, The Netherlands.
-
- Cissy Kityo
- Joint Clinical Research Centre, Kampala, Uganda.
収録刊行物
-
- AIDS Research and Human Retroviruses
-
AIDS Research and Human Retroviruses 29 (6), 925-930, 2013-06
Mary Ann Liebert Inc
